A senolytic is a compound that selectively eliminates senescent cells, which are cells that have stopped dividing but remain metabolically active, secreting a cocktail of inflammatory signals called SASP (Senescence-Associated Secretory Phenotype). Senolytics work by blocking the survival pathways that allow these cells to persist, triggering their selective clearance.

Dasatinib and Quercetin Clear Senescent Cells from Skin, Reducing Aging Markers

Q: Is quercetin available as a supplement?

Quercetin is found naturally in apples, onions, capers, and green tea, but dietary intake alone is unlikely to reach concentrations associated with senolytic effects. Clinical research has used supplemental doses in the 500mg~1,000mg range. Quercetin supplements typically cost $20~$50 per month. Dasatinib is a prescription chemotherapy drug and cannot be self-administered without medical supervision.

Q: What is SASP and how does it affect skin?

SASP (Senescence-Associated Secretory Phenotype) refers to the inflammatory factors secreted by senescent cells into surrounding tissue. These include IL-1α, IL-6, MMP-9 (a collagen-degrading enzyme), and MMP-12. They impair neighboring healthy cells, accelerate collagen breakdown, and create a chronic low-grade inflammatory environment that progressively degrades skin's regenerative capacity.

As skin ages, its capacity to regenerate slows. Wounds heal more slowly, collagen production declines, and the skin’s structural integrity becomes harder to maintain. One increasingly researched contributor to this decline is the accumulation of senescent cells: cells that have stopped dividing but remain biologically active, continuously secreting inflammatory signals that damage surrounding tissue. Research published in eBioMedicine (The Lancet group) presents clinical evidence that a senolytic combination, a compound that selectively eliminates these aging cells, can meaningfully reduce their burden in skin.

What Senescent Cells Do to Skin

Senescent cells are identified by expression of two biomarkers: p16INK4A and p21CIP1. Once a cell enters this state, it resists normal programmed death while secreting SASP (Senescence-Associated Secretory Phenotype) factors into the surrounding tissue. In skin, this SASP cocktail includes IL-1α, IL-6, MMP-9 (a matrix metalloproteinase that breaks down collagen), and MMP-12. The cumulative effect is a chronic inflammatory microenvironment that progressively erodes skin’s structural proteins and regenerative signaling capacity.

What Dasatinib and Quercetin Did

The study examined the combination of dasatinib (D) and quercetin (Q) in a clinical context originating from diabetic kidney disease research. D+Q reduced the expression of p16INK4A and p21CIP1-positive senescent cells in skin tissue. In blood, the SASP factors IL-1α, IL-6, MMP-9, and MMP-12 were reduced following treatment. Radiation-induced skin ulcers, a model for impaired skin regenerative capacity, also showed mitigation with D+Q. This diabetic kidney disease trial functioned as a proof-of-concept demonstrating that systemic senolytic effects reached peripheral tissues including skin.

Quercetin’s Unique Position

Quercetin is the only flavonoid in the senolytic class that has been tested in human clinical trials. It blocks senescent cell survival pathways including BCL-2 family proteins and PI3K/Akt signaling, triggering selective apoptosis in cells that healthy non-senescent cells do not depend on. Quercetin is naturally present in apples, onions, capers, and green tea, but dietary intake alone is insufficient to achieve the concentrations associated with senolytic activity. Supplemental doses used in clinical research range from 500mg to 1,000mg. Standalone quercetin supplements are widely available at $20~$50 per month.

Practical Context

Dasatinib is a prescription-only tyrosine kinase inhibitor used in leukemia treatment. The D+Q protocol remains in the clinical research domain and is not a standard supplement regimen. Quercetin on its own has a well-established anti-inflammatory and antioxidant profile that can be evaluated independently of its senolytic application. The broader framework, that targeting senescent cell accumulation represents a viable strategy for skin aging, is gaining scientific traction, but the specific protocols and populations that will benefit most from senolytic approaches continue to be defined.

Frequently Asked Questions

What is a senolytic? A senolytic selectively eliminates senescent cells, which stop dividing but continue secreting inflammatory SASP factors that damage surrounding tissue. Senolytics block the survival pathways senescent cells rely on, triggering their clearance without affecting healthy neighboring cells.

Is quercetin available as a supplement? Yes. Quercetin is the only clinically tested senolytic flavonoid and is widely available in supplement form at 500mg~~1,000mg doses for approximately $20~~$50 per month. Dasatinib is a prescription chemotherapy drug that requires medical supervision and cannot be self-administered.

What is SASP and how does it affect skin? SASP (Senescence-Associated Secretory Phenotype) is the set of inflammatory factors, including IL-1α, IL-6, MMP-9, and MMP-12, secreted by senescent cells. In skin, these factors degrade collagen, impair regenerative signaling, and create a chronic inflammatory environment that accelerates visible aging.

Source: eBioMedicine (The Lancet)